Skip to main content

Profile: Marc Fleming

fleming-marc.jpg
Marc L. Fleming, Ph.D., MPH, R.Ph.
Assistant Professor of Pharmaceutical Health Outcomes and Policy
University of Houston College of Pharmacy
Health and Biomedical Sciences Building 2, Room 4051
4849 Calhoun
College of Pharmacy
Houston, TX 77204-5000
832-842-8388
832-842-8383 (Fax)
MLFlemi2@central.uh.edu

Education & Post-graduate Training

Ph.D., Pharmacy (Health Outcomes and Pharmacy Practice), The University of Texas, Austin, Texas

M.S., Pharmacy Administration, The University of Texas, Austin, Texas

M.P.H., Virginia Commonwealth University, Richmond, Virginia

B.S. Pharmacy, Texas Southern University, Houston, Texas

Licensure & Certifications

Licensed Pharmacist, Texas State Board of Pharmacy

Texas State Board of Pharmacy Preceptor

Licensed Pharmacist, Virginia State Board of Pharmacy

Research Interests

My research interests are in the areas of pharmacy practice and health disparities. My dissertation research used the theory of planned behavior to examine Texas community pharmacists’ intended use of the online prescription drug monitoring program (PDMP), when making dispensing decisions regarding controlled prescriptions drugs (CPDs).  Under the authority of the Texas Department of Public Safety, the Texas PDMP tracks all of the CPDs dispensed from Texas community pharmacies. Other research interests are in medication use disparities of antidepressant medications and pain treatment and pharmacists’ interventions to improve medication adherence.

Media

Selected Publications

Peer Reviewed

Fleming ML, Driver L, Sansgiry SS, Abughosh S, Wanat M, Sawant RV*, Ferries EF*, Reeve K, Todd KH. Physicians’ intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach. Research in Social & Administrative Pharmacy. 2016 (in press).

Ferries EF*, Gilson AM, Aparasu RR, Chen H, Johnson ML, Fleming ML. Prevalence and factors associated with multiple provider episodes in Texas: an epidemiological analysis of prescription drug monitoring program data. Pain Medicine. 2016 Oct .

Hickerson SC*, Fleming ML, Sawant RV, Ordonez ND, Sansgiry SS. Predicting pharmacy students' intention to apply for a residency: A systematic theory of planned behavior approach. Currents in Pharmacy Teaching & Learning. [Epub ahead of print] 2016 Aug.

Bhansali AH*, Fleming ML, Sherer JT, Sansgiry S. Improving Information Processing: The effect of label format among current and potential over-the-counter medication users. Therapeutic Innovation and Regulatory Science. 2016 March.

Bali V, Holmes HM, Johnson ML, Chen H, Fleming ML, Aparasu RR. Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression. Pharmacotherapy. 2016 Jan;36(1):38-48. doi: 10.1002/phar.1680. Epub 2016 Jan 9. PMID: 26748455

Abughosh SM, Wang X*, Serna O, Henges C*, Masilamani S, Essien EJ, Chung N, Fleming ML. A pharmacist telephone intervention to identify adherence barriers and improve adherence among nonadherent patients with comorbid hypertension and diabetes in a Medicare Advantage plan. Journal of Managed Care & Specialty Pharmacy. 2016;22(1):63-73.

Bali V, Johnson ML, Chen H, Fleming ML, Holmes HM, Aparasu RR. Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression. Ann Pharmacother. 2016 Feb;50(2):96-105. doi: 10.1177/1060028015618978. Epub 2015 Nov 25. PMID: 26610873

Fleming ML, Phan Y, Ferries EA, Hatfield MD. Educating Pharmacists on a Prescription Drug Monitoring Program. J Pharm Pract. 2015 May 6. pii: 0897190015579448. [Epub ahead of print] PMID: 25947949

Fleming ML, Wanat MA. To prescribe codeine or not to prescribe codeine? J Pain Palliat Care Pharmacother. 2014 Sep;28(3):251-4. doi: 10.3109/15360288.2014.938888. Epub 2014 Aug 7. PMID: 25102040

Wanat MA, Fleming ML, Fernandez JM, Garey KW. Education, training, and academic experience of newly hired, first-time pharmacy faculty members. Am J Pharm Educ. 2014 Jun 17;78(5):92. doi: 10.5688/ajpe78592. PMID: 24954932

Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels SA, Novak S. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions. J Am Pharm Assoc (2003). 2014 May-Jun;54(3):241-50. doi: 10.1331/JAPhA.2014.13168. PMID: 24816350

Fleming ML, Hatfield MD, Wattana MK, Todd KH. Exploratory study of emergency physicians' use of a prescription monitoring program using a framework of technology acceptance. J Pain Palliat Care Pharmacother. 2014 Mar;28(1):19-27. doi: 10.3109/15360288.2013.879242. Epub 2014 Feb 12. PMID: 24520884

Gavaza P, Fleming ML, Barner JC. Examination of Psychosocial Predictors of Virginia pharmacists’ intention to utilize a prescription drug monitoring program using the theory of planned behavior. Research in Social & Administrative Pharmacy. 2014;10(2):448-58.

Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels S, Novak S. Using the theory of planned behavior to examine pharmacists’ intention to utilize a prescription drug monitoring program database. Res Social Adm Pharm. 2013 Jun 29. doi:pii: S1551-7411(13)00096-X. 10.1016/j.sapharm.2013.05.009. [Epub ahead of print]

Fleming ML, Chandwani H, Barner JC, Weber SN, Okoro TT. Prescribers and pharmacists requests for Prescription Monitoring Program (PMP) data: Does PMP structure matter? J Pain Palliat Care Pharmacother. 2013 Jun;27(2):136-142.

Fleming ML, Nemlekar PM, Brown CM, Cantu RE. Exploratory study of community pharmacists’ perceptions about new or transferred prescription incentives,J Am Pharm Assoc, 2011. (early online edition) 2012;52:e53-e58.

Fleming ML, Barner JC, Brown CM, Smith, TB. Treatment disparities for major depressive disorders: implications for pharmacists. J Am Pharm Assoc, 2011; Sep-Oct;51(5):605-12.

Non-Peer Reviewed

Fleming ML. PDMPs: An Inside Look at Research in Progress. Student Pharmacist. 2010;7(2):12.

Abstracts & Presentations

Poster Presentations (peer reviewed)

Fleming ML, Driver L, Sansgiry SS, Sawant RV, Abughosh S, Wanat M, Pickard T, Reeve K, Todd KH. “Impact of hydrocodone rescheduling on texas physicians’ future pain management” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Washington, DC, May 21-25, 2016.

Fleming ML, Driver L, Sansgiry SS, Sawant RV, Abughosh S, Wanat M, Pickard T, Reeve K, Todd KH. “Predicting Texas physicians’ intention to prescribe hydrocodone combination products after rescheduling” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Washington, DC, May 21-25, 2016.

Atreja N*, Fleming ML, Chen H, Johnson ML, Zhivan N, Todd KH. “Impact Of long term opioid use on oral antihyperglycemic medication adherence among individuals with type 2 diabetes mellitus: A retrospective database analysis” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Washington, DC, May 21-25, 2016.

Hatfield MD*, Sansgiry SS, Johnson ML, Essien EJ, Fleming ML. “Rescheduling hydrocodone combination products: assessing the impact on opioid utilization” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Washington, DC, May 21-25, 2016.

Bhansali A*, Sansgiry SS, Serna O, Fleming ML, Abughosh S, Kamdar M, Stanford R. “Assessment Of Medicare Advantage prescription drug coverage gap among COPD patients: analysis of hospitalization use” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Washington, DC, May 21-25, 2016.

Fleming ML, Hatfield MD, Sawant RV. “Qualitative assessment of pharmacists’ use of prescription drug monitoring program data and attitudes towards patient engagement” presented as an oral poster session of the ESAS research day, Baltimore, MD, March 4, 2016.

Wang X*, Serna O, Henges C, Essien EJ, Chung N, Fleming ML, Abughosh S. “Impact of a pharmacist telephone intervention on preventing medication discontinuation among hypertensive patients with diabetes in a Medicare Advantage plan” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Abughosh SM, Wang X, Serna O, Henges C, Essien EJ, Masilamani S, Fleming ML. “Impact of a pharmacist telephone intervention on medication adherence among hypertensive patients with diabetes in a Medicare Advantage plan” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Atreja N*, Fleming ML. “Medication utilization pattern for pain management among individuals with type 2 diabetes” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Hatfiled MD*, Fleming ML. “Use of hydrocodone/acetaminophen: prevalence and estimating emergency department visits” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Hatfiled MD*, Fleming ML. “Hydrocodone: a review of the literature” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Philadelphia, PA, May 16-20, 2015.

Hatfield MD*, Wattana MK, Todd KH, Fleming ML. “Emergency physicians’ intention to use the Texas prescription monitoring program” presented at the Internationa Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Montreal, QC, Canada, May 31-June 4, 2014.

Patel H*, Essien EJ, Fleming ML, Mehta P, Sherer JT, Sansgiry SS. “Development and testing of patient drug information leaflets to improve comprehension” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Montreal, QC, Canada, May 31-June 4, 2014.

Chao J*, Eppinette R*, Pourarsalan H*, Fleming ML. “Community chain pharmacists perceptions of medication therapy management and awareness of pharmacy quality alliance measures” presented at the Academy of Managed Care Pharmacy Annual Meeting, Tampa, FL, April 1 – 4, 2014.

Garcia L, Mhatre S, Serna O, Sansgiry S, Esse T, Fleming ML. “Examining pharmacist led recommendations to physicians within a Medicare Advantage pla (MAP)” presented at the Academy of Managed Care Pharmacy Annual Meeting, Tampa, FL April 1 – 4, 2014.

Henges C*, Fleming ML, Serna O, Mhatre S*, Sansgiry S. “Effect of a pharmacist-led telephone call to identify barriers and improve medication adherence in patients enrolled in a Medicare Advantage plan” presented at the Academy of Managed Care Pharmacy Annual Meeting, Tampa, FL, April 1 – 4, 2014.

Fleming ML, Upadhyay N*. “Chronic medication adherence among opioid users in a Medicare Advantage plan” presented at the American Pharmacists Association Annual Meeting, Orlando, FL, March 27-31, 2014.

Fleming ML, Wattana MK, Hatfield MH*, Todd KH. “Exploratory study of emergency physicians’ use of a prescription drug monitoring program using a framework of technology acceptance” at the American College of Emergency Physicians (ACEP) Annual Meeting, Seattle, WA, October 14-15, 2013.

Fleming ML, Wattana MK, Hatfield MH*, Todd KH. “Understanding emergency physicians’ intention and use of a prescription drug monitoring program” at the Mediterranean Emergency Medicine Conference, Marseille, France, September 8-11, 2013.

Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels SA, Novak S. “Texas community pharmacists’ views and actions regarding dispensing controlled prescription drugs” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, New Orleans, LA, May 20, 2013.

Haynes LN*, Patel AV*, Aparasu RR, Fleming ML, Fernandez NA, Newcomer KF, Serna O. “Examining medications with high monitoring program: A pilot study” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Montreal, QC, Canada, May 31-June 4, 2014.

Ferries EA*, Fleming ML, Hatfield MD, Atreja N, Yucel A, Rane PP, Sharma M, Wang X. “Patients’ expectations and intentions to receive medication counseling from community pharmacists” presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Montreal, QC, Canada, May 31-June 4, 2014.

Abughosh S, Wang X*, Henges C, Fleming ML, Serna O. “Adherence barriers to ace-is and arbs among non-adherent hypertensive patients with diabetes enrolled in a Medicare advantage plan” presented at the anticholinergic activity and adverse events among older adults enrolled in a Medicare Advantage plan: A Retrospective Analysis” at the Academy of Managed Care Pharmacy Annual Meeting, San Diego, CA, April 3-5, 2013.

Jaffar AF*, Aparasu R, Fleming ML, Patel AV*, Fernandez NA, Newcomer KF, Serna O. “Evaluating anticholinergic agents and adverse events in patients diagnosed with dementia: a retrospective analysis” Poster at the Presented at the Academy of Managed Care Pharmacy Annual Meeting, San Diego, CA, April 3-5, 2013.

Fleming ML, Barner JC, Lajide CL. “Pharmacists' Beliefs Regarding Intention To Utilize Prescription Drug Monitoring Program (PDMP) Data” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Washington, DC, June 4, 2012.

Fleming ML, Chandwani HS, Barner JC, Weber SN, Okoro TT. “Prescription Monitoring Program (PMP) Utilization” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Baltimore, MD, May 23, 2011.

Fleming ML, Nemlekar PM, Brown CM, Cantu RE. “Survey of Texas Community Pharmacists’ Perceptions about New or Transferred Prescription Incentives” at the American Pharmacists Association Annual Meeting, Seattle, WA, March 25-28, 2011.

Fleming ML, Barner JC, Brown CM, Shepherd MD, Strassels SA, Novak S. “Using the Theory of Planned Behavior to Predict Texas Community Pharmacists’ Intention to Utilize an On-line Prescription Monitoring Database as an Aid in Determining Whether or Not to Dispense a Controlled Substance Medication” (research in progress) at the Southern Pharmacy Administration Conference, Memphis, TN, June 18-20, 2010.

Fleming ML, Barner JC, Bamgbade BA. “Mortality Rate Comparison between States with and without Prescription Drug Monitoring Programs and Associated Federal Costs” at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Atlanta, GA, May 18, 2010.

Fleming ML, Barner JC, Brown CM, Bettinger T. “Depression Treatment by Race: An Examination of Pharmacotherapy, Provider, and Complementary and Alternative Medicine (CAM)” at the American Pharmacists Association Annual Meeting, San Antonio, TX, April 3-6, 2009.

Invited Presentations

Fleming ML. “Drugs of Abuse from the Pharmacy,” presented at the 14th Annual Fall Prevention Provider Meeting Prevention Day in Texas: Prevention Matters. Austin, TX, (September 2016).

Fleming ML. Presentation to Mercer College of Pharmacy students regarding the opportunities for PharmD/PhD in pharmacy health outcomes research, Macon,GA. (March 2016).

Fleming ML. “The Changing Landscape in Pain Management,” presented at the Texas Health-System Pharmacists Annual Seminar, San Antonio, TX, (April 2015).

Fleming ML. “Legislation of Controlled Substances in Pharmacy” Presentation to the UH Student National Pharmaceutical Association, Houston,TX (November 2014)

Fleming ML. “Graduate Studies in Disciplines Associated with Pharmacy.” Introduction to Pharmacy; P1 Course, The University of Texas College of Pharmacy, Austin, TX (April 2009).

Fleming ML. “Graduate School in Pharmacy,” UT Rho-Chi Honor Society Chapter Meeting, The University of Texas College of Pharmacy, Austin, TX (October 2008).

Barner JC, Brown CM, Devine L, Fleming ML, Gavaza P. “Career Opportunities in Pharmacy” The African-American Men and Boys Conference, Connally High School, Austin, TX (April 2007).

Fleming ML. “Introduction to Pharmacy Graduate Programs.” The University of Texas at Austin-Student National Pharmaceutical Association Chapter Meeting, The University of Texas College of Pharmacy, Austin, TX (October 2005).

Fleming ML. “The Future of Public Health” Masters of Public Health Graduation Commencement Ceremony, Virginia Commonwealth University, Richmond, VA (May 2000).

Other Presentations

Fleming ML, Nemlekar P. “Meta-Analysis” The University of Texas College of Pharmacy, Graduate Seminar (November 2008).

Fleming ML. Presentation on significant articles in medicine. “The etiology of yellow fever. A preliminary note.” Reed W, Carroll J, Agramonte A, Lazear JW,.Philadelphia Med J 1900; 6: 790-96.” The University of Texas College of Pharmacy, Graduate Seminar (February 2008).

Cantu R, Fleming ML. “Andersen’s Behavioral Model of Health Services Utilization” The University of Texas College of Pharmacy, Graduate Seminar (September 2007).

Fleming ML, Tiwana S. “National Health and Nutrition Survey (NHANES)” The University of Texas College of Pharmacy, Graduate Seminar (October 2006).

Corbell Z, Fleming ML. “Drug Patent Term Extensions” The University of Texas College of Pharmacy, Graduate Seminar (November 2005).

Awards & Honors

  • Postgraduate Best Podium Presentation Award, American Pharmacists Association's Academy of Pharmacy Research and Science-Economic, Social and Administrative Sciences Section, APhA Annual Meeting, Los Angeles, CA, March 2013
  • Honorable Mention (2nd place) for Best Poster Presentation at the APhA 2011 Annual Meeting, Seattle, WA, March 2011
  • 3rd place for Best Poster Presentation at the Southern Pharmacy Administration Conference, Memphis, TN, June 2010
  • 1st place for Student Chapters Research Competition at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Toronto, Canada, May 2008
  • Wal-Mart Scholar, Awarded by Wal-Mart at the American Association of Colleges of Pharmacy Annual Meeting, Orlando, Florida, July 2007
  • 2nd place for Student Chapters Research Competition at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, Arlington, Virginia, May 2007
  • Smith Kline Beecham Award for Patient Care, Texas Southern University, May 1996

Professional Service & Affiliations

  • Academy of Managed Care Pharmacy (AMCP), 2013–2015
  • American Association of Colleges of Pharmacy (AACP), 2012–present
  • American Society of Health-System Pharmacists (ASHP), 2013–2015
  • American Pharmacists Association, 1997-present
  • International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 2005-present
  • International Society for Pharmacoepidemiology (ISPE), The University of Texas Student Chapter, 2006-2012
  • Rho Chi Honor Society, 2008-present